Apolipoprotein E4 isoform-specific actions on neuronal cells in culture

Mechanisms of Ageing and Development

Volumn 107, Issue 3, 1999, Pages 233-243

  Michikawa, Makoto ^a   Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholesterol synthesis; HMG CoA reductase; Neuronal cell death

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; COMPACTIN; DNA FRAGMENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; SQUALENE; SQUALENE SYNTHASE; SQUALESTATIN; VERY LOW DENSITY LIPOPROTEIN;

ALLELE; ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; FETUS; NERVE CELL; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033558961     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(98)00134-1     Document Type: Conference Paper

References (27)

1. Bellosta, S., Nathan, B.P., Orth, M., Dong, L.M., Mahley, R.W., Pitas, R.E., 1995. Stable expression and secretion of apolipoprotein E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270, 27063-27071.
2. Bodovitz, S., Klein, W.I., 1996. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440.
3. Bohnet, K., Pillot, T., Visvikis, S., Sabolovic, N., Siest, G., 1996. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J. Lipid Res. 37, 1316-1324.
4. Bottenstein, J.E., Sato, G.H., 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76, 514-517.
5. Corder, E.H., Sauders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, G.W., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
6. Crick, D.C., Suders, J., Kluthe, C.M., Andres, D.A., Waechter, C.J., 1995. Selective inhibition of cholesterol biosynthesis in brain cells by squalestatin 1. J. Neurochem. 65, 1365-1373.
7. Fagan, A., Bu, G., Sun, Y., Daugherty, A., Holzman, D., 1996. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 30121-30125.
8. Goldstein, J.L., Brown, M.S., 1990. Regulation of the mevalonate pathway. Nature 343, 425-430.
9. Guillaume, D., Bertrand, P., Dea, D., Davignon, J., Poirier, J., 1996. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations. J. Neurochem. 66, 2410-2418.
10. Holzman, D.M., Pitas, R.E., Kilbridge, J., Nathan, B., Mahley, R.W., Bu, G., Schwartz, A.L., 1995. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neruonal cell line. Proc. Natl. Acad. Sci. USA 92, 9480-9484.
11. Jordan, J., Galindo, M.F., Miller, R.J., Reardon, C.A., Getz, G.S., LaDu, M.J., 1998. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18, 195-204.
12. Ma, J.H., Brewer Jr, B., Potter, H., 1996. Alzhiemer Aβ neurotoxicity: promotion by antichymotrypsin, apoE; inhibition by Aβ-related peptides. Neurobiol. Aging 17, 773-780.
13. Marques, M., Tolar, M., Crutcher, K., 1997. Apolipoprotein E exhibits isoform-specific neruotoxicity. Alzheimer Res. 3, 1-6.
14. Marques, M., Tolar, M., Harmony, J., Crutcher, K., 1996. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport 7, 2529-2532.
15. Mason, R.P., Shoemaker, W.J., Shajenko, L., Chambers, T.E., Herbette, L.G., 1992. Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging 13, 413-419.
16. Michikawa, M., Kikuchi, S., Muramatsu, H., Muramatsu, T., Kim, S.U., 1993. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J. Neurosci. Res. 35, 530-539.
17. Miyata, M., Smith, J.D., 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nature Genet. 14, 55-61.
18. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W., Pitas, R.E., 1994. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
19. Nathan, B.P., Chang, K.C., Bellosta, S., Brisch, E., Ge, N., Mahley, R.W., Pitas, R.E., 1995. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270, 19791-19799.
20. Nicoll, J.A.R., Roberts, G.W., Graham, D.J., 1995. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135-137.
21. Poirier, J., Baccichet, A., Dea, D., Gauthier, S., 1993. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90.
22. Racchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, P., Fumagalli, R., Govoni, S., Trabucchi, M., Soma, M., 1997. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322, 893-898.
23. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-Maclachlan, D.R., Growden, J., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D., Roses, A.D., 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
24. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L-M., Jakes, R., Hunag, D.Y., Pericak-Vance, M., Schmechel, D., Roses, A.D., 1993. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183-11186.
25. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., Roses, A.D., 1993. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
26. Tolar, M., Marques, M., Harmony, J., Crutcher, K., 1997. Neurotoxicity of the 22 kDa thrombin-cleav-age fragment of apolipoprotein E related synthetic peptides is receptor-mediated. J. Neurosci. 17, 5678-5686.
27. Weisgraber, K.H., Innerarity, T.L., Mahley, R.W., 1982. Abnormal lipoprotein receptor-binding activity of the human apolipoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257, 2518-2521.